ETV6/ARG oncoprotein confers autonomous cell growth by enhancing c-Myc expression via signal transducer and activator of transcription 5 activation in the acute promyelocytic leukemia cell line HT93A

References

• O’Brien SG, Guilhot F, Larson RA, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003;348: 994–1004.
   PubMed Web of Science ®Google Scholar
• Yanada M, Takeuchi J, Sugiura I, et al. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia:a phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol 2006;24:460–466.
   PubMed Web of Science ®Google Scholar
• De Braekeleer E, Douet-Guilbert N, Morel F, et al. ETV6 fusion genes in hematological malignancies: a review. Leuk Res 2012 ;36: 945–961.
   PubMed Web of Science ®Google Scholar
• Iijima Y, Ito T, Oikawa T, et al. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation. Blood 2000;95:2126–2131.
   PubMed Web of Science ®Google Scholar
• Cazzaniga G, Tosi S, Aloisi A, et al. The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal transcripts. Blood 1999;94:4370–4373.
   PubMed Web of Science ®Google Scholar
• Gao N, Li ZH, Ding BT, et al. Expression of ETV6 rearrangement in a subject with acute myeloid leukemia-M4Eo. Chin Med J (Engl) 2008;121:1744–1746.
   PubMed Web of Science ®Google Scholar
• Griesinger F, Janke A, Podleschny M, et al. Identification of an ETV6-ABL2 fusion transcript in combination with an ETV6 point mutation in a T-cell acute lymphoblastic leukaemia cell line. Br J Haematol 2002;119:454–458.
   PubMed Web of Science ®Google Scholar
• Iijima Y, Okuda K, Tojo A, et al. Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG. Oncogene 2002;21:4374–4383.
   PubMed Web of Science ®Google Scholar
• Kruh GD, Perego R, Miki T, et al. The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc Natl Acad Sci USA 1990;87:5802–5806.
   PubMed Web of Science ®Google Scholar
• Kishi K, Toba K, Azegami T, et al. Hematopoietic cytokine-dependent differentiation to eosinophils and neutrophils in a newly established acute promyelocytic leukemia cell line with t(15;17). Exp Hematol 1998;26:135–142.
   PubMed Web of Science ®Google Scholar
• Nishimura N, Furukawa Y, Sutheesophon K, et al. Suppression of ARG kinase activity by STI571 induces cell cycle arrest through up-regulation of CDK inhibitor p18/INK4c. Oncogene 2003;22:4074–4082.
   PubMed Web of Science ®Google Scholar
• Weisberg E, Manley PW, Breitenstein W, et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell 2005;7:129–141.
   PubMed Web of Science ®Google Scholar
• Saglio G, Kim DW, Issaragrisil S, et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 2010;362:2251–2259.
   PubMed Web of Science ®Google Scholar
• Iriyama N, Yuan B, Yoshino Y, et al. Enhancement of differentiation induction and upregulation of CCAAT/enhancer-binding proteins and PU.1 in NB4 cells treated with combination of ATRA and valproic acid. Int J Oncol 2014;44:865–73.
   PubMed Web of Science ®Google Scholar
• Okuda K, Weisberg E, Gilliland DG, et al. ARG tyrosine kinase activity is inhibited by STI571. Blood 2001;97:2440–2448.
   PubMed Web of Science ®Google Scholar
• Tian SS, Tapley P, Sincich C, et al. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes. Blood 1996;88:4435–4444.
   PubMed Web of Science ®Google Scholar
• Shimozaki K, Nakajima K, Hirano T, et al. Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J Biol Chem 1997;272:25184–25189.
   PubMed Web of Science ®Google Scholar
• Tian SS, Lamb P, Seidel HM, et al. Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 1994;84:1760–1764.
   PubMed Web of Science ®Google Scholar
• Sperling C, Schwartz S, Buchner T, et al. Expression of the stem cell factor receptor C-KIT (CD117) in acute leukemias. Haematologica 1997;82:617–621.
   PubMed Web of Science ®Google Scholar
• Iriyama N, Yuan B, Hatta Y, et al. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A. Oncol Rep 2012;28: 1875–1882.
   PubMed Web of Science ®Google Scholar
• Kelly LM, Gilliland DG. Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 2002;3:179–198.
   PubMed Web of Science ®Google Scholar
• Takahashi S. Current findings for recurring mutations in acute myeloid leukemia. J Hematol Oncol 2011;4:36.
   PubMed Web of Science ®Google Scholar
• Gesbert F, Sellers WR, Signoretti S, et al. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway. J Biol Chem 2000; 275:39223–39230.
   PubMed Web of Science ®Google Scholar
• Jonuleit T, van der Kuip H, Miething C, et al. Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines. Blood 2000;96:1933–1939.
   PubMed Web of Science ®Google Scholar
• Mysliwiec T, Perego R, Kruh GD. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain. Oncogene 1996;12:631–640.
   PubMed Web of Science ®Google Scholar
• Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009;9:400–414.
   PubMed Web of Science ®Google Scholar
• Matikainen S, Sareneva T, Ronni T, et al. Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood 1999;93:1980–1991.
   PubMed Web of Science ®Google Scholar
• Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002;8:945–954.
   PubMed Web of Science ®Google Scholar
• Gesbert F, Griffin JD. Bcr/Abl activates transcription of the Bcl-X gene through STAT5. Blood 2000;96:2269–2276.
   PubMed Web of Science ®Google Scholar
• Sillaber C, Gesbert F, Frank DA, et al. STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells. Blood 2000;95:2118–2125.
   PubMed Web of Science ®Google Scholar